US 7964359
Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance
granted A61KA61K38/28
Quick answer
US patent 7964359 (Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance) held by Acumen Pharmaceuticals, Inc. expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acumen Pharmaceuticals, Inc.
- Grant date
- Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/28